And finally, adult-use cannabis sales exceeded medicinal sales for the first time. All this took one year... and most of it happened toward the end of the year. Now we are in 2019 and the cannabis market is ready to hit the gas pedal. But there are still plenty of reasons to be cautious before investing in any cannabis companies. Many have been overly promoted by unknown managements with questionable backgrounds. In Canada, many began as mining companies turned cannabis companies. So please, do your homework before buying in. My team and I have combed through all kinds of information. We’ve interviewed management teams and other entrepreneurs in this new industry. The market is huge, the companies are becoming “real,” and
In 2018, legal global cannabis sales were $12.2 billion. This is projected to more than double to $31 billion by 2022, a mere four years from now. Another independent source suggests the legal global market will reach $146 billion by 2025. That represents an average annual growth rate of 42%. And even if this estimate is overly optimistic and we only get halfway to the $146 billion, it is still a 30% annual growth rate. Few other markets grow this fast year after year. Take health care spending... Even though premiums go up every year, copays rise, and prescription drugs keep rocketing higher... total national health expenditures as tracked and reported by the Centers for Medicare and Medicaid Services (CMS) increased around 6.5% per year between 1990-2016.
support for full legalization in the U.S. is gaining traction.
BIG AND GROWING MARKET SIZE As mentioned above, we believe the opportunity is potentially greater than the Prohibition analogy. Medical and adult-use cannabis in the U.S. alone will disrupt markets where current spending is more than $500 billion.
American Consequences 33
Made with FlippingBook - professional solution for displaying marketing and sales documents online